English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52735098    線上人數 :  675
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"shihchen"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 11-20 / 24 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國立成功大學 2021-03 Association of adherence to antiretroviral therapy with economic burden of cardiovascular disease in HIV-infected population Liao;Chia-Te;Yang;Chun-Ting;Chen;Pin-Hao;Toh;Siong, Han;Kuo;Shihchen;Chen;Zhih-Cherng;Ou;Huang-Tz;Ko;Nai-Ying;Wang;Jung-Der
國立成功大學 2021-03 Heterogeneous Treatment Effects on Cardiovascular Diseases With Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas in Type 2 Diabetes Patients Yang;Chen-Yi;Lin;Wei-Ann;Su;Pei-Fang;Li;Lun-Jie;Yang;Chun-Ting;Ou;Huang-Tz;Kuo;Shihchen
國立成功大學 2021-02-18 A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes Yang;Chun-Ting;Li;Kuan-Ying;Yang;Chen-Yi;Ou;Huang-Tz;Kuo;Shihchen
國立成功大學 2021-02 Hepatic and cardiovascular safety of acarbose among type 2 diabetes patients with end-stage renal disease: A nationwide population-based longitudinal study Lin;Wei-Hung;Yang;Chen-Yi;Kuo;Shihchen;Kuo;Te-Hui;Roan;Jun-Neng;Li;Chung-Yi;Wang;Ming-Cheng;Ou;Huang-Tz
國立成功大學 2021-01-19 Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review Yang;Chen-Yi;Chen;Ying-Ren;Ou;Huang-Tz;Kuo;Shihchen
國立成功大學 2020-11-5 Association of ambient air pollution with cardiovascular disease risks in people with type 2 diabetes: a Bayesian spatial survival analysis Su;Pei-Fang;Sie;Fei-Ci;Yang;Chun-Ting;Mau;Yu-Lin;Kuo;Shihchen;Ou;Huang-Tz
國立成功大學 2020-10-9 Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis Chang;Kai-Cheng;Shao;Shih-Chieh;Kuo;Shihchen;Yang;Chen-Yi;Chen;Hui-Yu;Chan;Yuk-Ying;Ou;Huang-Tz
國立成功大學 2020-08 Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up Chen;Hsuan-Ying;Kuo;Shihchen;Su;Pei-Fang;Wu;Jin-Shang;Ou;Huang-Tz
國立成功大學 2020-07-6 Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes Yang;Chen-Yi;Su;Pei-Fang;Hung;Jo-Ying;Ou;Huang-Tz;Kuo;Shihchen
國立成功大學 2020-06-13 Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: a nationwide population-based cohort study Yang;Chun-Ting;Yang;Chen-Yi;Ou;Huang-Tz;Kuo;Shihchen

顯示項目 11-20 / 24 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目